Search results
Results From The WOW.Com Content Network
Drug abuse retinopathy is damage to the retina of the eyes caused by chronic drug abuse. Types of retinopathy caused by drug abuse include maculopathy, Saturday night retinopathy, and talc retinopathy. Common symptoms include temporary and permanent vision loss, blurred vision, and night blindness.
Symptoms may include elevated body temperature, blurred vision, dilated pupils, sleepiness, confusion, seizures, rapid heart rate, and cardiac arrest. [1] If symptoms have not occurred within six hours of exposure they are unlikely to occur. [2] TCA overdose may occur by accident or purposefully in an attempt to cause death. [2]
Symptoms: Constricted pupils: ... condition, mydriasis, is the dilation of the pupil. ... altered level of consciousness caused by the sedative effect of the drug.
Side effects include eye aches, dilated pupils, headaches, nearsightedness, or blurred or dimmed vision. ... linked to macular degeneration symptoms. Of all the drugs discussed, this one generally ...
When symptoms increase periodically during protracted withdrawal, physiological changes may be present, including dilated pupils as well as an increase in blood pressure and heart rate. [9] The change in symptoms has been proposed to be due to changes in receptor sensitivity for GABA during the process of tolerance reversal. [25]
Dilation and constriction of the pupil Pupillary response is a physiological response that varies the size of the pupil between 1.5 mm and 8 mm, [ 1 ] via the optic and oculomotor cranial nerve. A constriction response ( miosis ), [ 2 ] is the narrowing of the pupil, which may be caused by scleral buckles or drugs such as opiates / opioids or ...
The revised risk index for overdose or severe opioid induced respiratory depression (RIOSORD) is a validated screening tool that may be used to estimate the risk of overdose in people using opioids, or the rapid opioid dependence screen may be used as a more rapid and succinct method to screen for opioid use disorder. [24] Other "drug seeking ...
Shares of the company rose 14% to $16.19 in morning trading as the drug met the trial's main and secondary goals in patients with the rare disorder that is estimated to affect between 90 and 300 ...